SNF occupancy remains stagnant as labor crisis limits admissions: NIC … Researchers call for more actionable policies around oral health in long-term care
Record use of staffing agencies, OT found as largest upswings in occupancy take place: NIC
By
Danielle Brown
Apr 19, 2021
Difficulties finding and retaining workers continue to plague long-term care operators more than a year into the COVID-19 pandemic, according to the latest data from the National Investment Center for...
Even amid COVID surge, many seniors housing operators not increasing move-in restrictions: NIC
By
Amy Novotney
Jan 15, 2021
Roughly two-thirds of long-term care organizations report that they have not increased move-in restrictions. Operators presumably are now more confident in infection prevention and creative, safe visitation...
NIH spending nearly $470 million on ‘long-haul COVID’ study
Sep 16, 2021
Goal is to uncover why some people have prolonged symptoms or develop new or returning symptoms after recovering from COVID-19
COVID-19 rapid test makers struggling to meet demand
Jan 21, 2022
However, government’s order for the free test kits is in addition to existing supply and does not interfere with existing orders
Burden of persistent symptoms high after COVID-19 infection
May 24, 2022
– A high burden of persistent symptoms is observed in persons after COVID-19, but no specific causes of symptoms of postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2)...
Long COVID may qualify as a disability: Biden
Jul 27, 2021
Some recovered COVID-19 patients have lasting problems such as fatigue, brain fog, joint pain, fever, and double vision
Common autoimmune drugs reduce mortality, up clinical status in COVID-19: NIH
By
Alicia Lasek (f3)
Jun 06, 2022
Two commonly used autoimmune drugs could be used in addition to standard-of-care treatments to improve COVID-19 outcomes, the agency says.
Feds look to OTC drugs for self-treatment of mild, moderate COVID
By
Alicia Lasek
Apr 21, 2021
A large trial is set to study the potential for repurposed, over-the-counter drugs to treat mild-to-moderate COVID-19 symptoms. If found effective, the approval timeline will likely be short, according...
NIH: COVID rebound after Paxlovid may signal a strong immune response
By
Alicia Lasek
Oct 11, 2022
Patients who had rebound symptoms after taking Paxlovid showed a more robust immune response to SARS-CoV-2 than patients with no rebound, investigators reported.